Table 1.
Patients’ demographics
| Patient number | Age at surgery (years), sex | Diagnosis, localization and side | Treatment | geneX® (cc) | Allergy | Smoker (pack years) | Alcohol use | Complication | Followup (months) | Time until event (days) | Goslings & Gouma grade |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 37, F | Enchondroma, proximal humerus, R | Curettage | 50 | None | 4.5 | Yes | None | 29 | – | 0 |
| 2 | 32, F | Enchondroma, hand, fifth digit L | Curettage | 5 | Ibuprofen | No | No | Aseptic inflammation | 27 | 7 | 1 |
| 3 | 23, M | Enchondroma, proximal humerus, R | Curettage, plate | 10 | None | 8 | Yes | None | 12 | – | 0 |
| 4 | 26, M | Enchondroma, hand, fifth digit, L | Curettage | 5 | None | No | Yes | None | 20 | – | 0 |
| 5 | 52, M | Enchondroma, hand, fifth digit, L | Curettage | 5 | None | 35 | No | None | 12 | – | 0 |
| 6 | 57, F | Enchondroma, hand, second digit, R | Curettage | 5 | Tramadol hydrochloride | 20 | Yes | None | 11 | – | 0 |
| 7 | 37, F | Enchondroma, hand, fifth digit, L | Curettage | 10 | None | 4.5 | Yes | None | 33 | – | 0 |
| 8 | 58, F | Intraosseous ganglion, foot, first digit, L | Curettage | 5 | None | No | No | None | 14 | – | 0 |
| 9 | 38, F | Enchondroma, hand, fourth digit, L | Curettage | 5 | None | 23 | No | None | 31 | – | 0 |
| 10 | 42, F | Enchondroma, hand, fifth digit, L | Curettage | 5 | None | 18.75 | Yes | None | 31 | – | 0 |
| 11 | 49, F | Intraosseous ganglion, hand, third digit, L | Curettage | 5 | NA | NA | NA. | None | 30 | – | 0 |
| 12 | 71, M | Chondrosarcoma grade 1, proximal humerus, L | Curettage | 30 | None | No | Yes | None | 12 | – | 0 |
| 13 | 50, F | Chondrosarcoma grade 1, proximal humerus, L | Curettage | 20 | None | 74 | Yes | None | 19 | – | 0 |
| 14 | 6, M | Juvenile bone cyst, proximal femur, L | Curettage | 10 | None | No | No | None | 15 | – | 0 |
| 15 | 26, F | Fibrous dysplasia, distal tibia, R | Curettage | 10 | None | No | No | None | 22 | – | 0 |
| 16 | 23, F | Intraosseous ganglion, calcaneus, R | Curettage | 5 | None | No | No | Pain* | 16 | – | 1 |
| 17 | 47, F | Enchondroma, distal femur, R | Curettage, plate | 10 | Mefenamic acid | No | No | None | 14 | – | 0 |
| 18 | 13, F | Nonossifying fibroma, proximal fibula, R | Curettage | 15 | None | No | No | None | 15 | – | 0 |
| 19 | 16, M | Fibrous dysplasia, distal tibia, L | Curettage, plate | 20 | None | 0.25 | No | None | 19 | – | 0 |
| 20 | 44, F | Chondrosarcoma grade 1, distal femur, L | Curettage, plate | 50 | None | No | No | None | 25 | – | 0 |
| 21 | 44, M | Intraosseous ganglion, distal femur, L | Curettage | 15 | Potassium dichromate | No | No | Soft tissue cyst | 10 | 52 | 1 |
| 22 | 63, M | Enchondroma, distal femur, R | Curettage, plate | 30 | Hornets | 60 | Yes | None | 20 | – | 0 |
| 23 | 50, F | Enchondroma, proximal humerus, L | Curettage | 15 | None | No | Yes | None | 13 | – | 0 |
| 24 | 57, F | Enchondroma, distal femur, R | Curettage, plate | 15 | None | No | Yes | None | 12 | – | 0 |
| 25 | 57, F | Enchondroma, proximal tibia, R | Curettage, plate | 30 | Iodine, acetylsalicylic acid | 22.5 | No | Aseptic inflammation | 18 | 15 | 1 |
| 26 | 42, F | Enchondroma, proximal humerus, R | Curettage | 30 | Pollen | No | Yes | None | 14 | – | 0 |
| 27 | 63, F | Enchondroma, proximal fibula, L | Curettage | 10 | None | No | No | Pain* | 8 | – | 0 |
| 28 | 38, F | Intraosseous lipoma, proximal humerus, R | Curettage | 30 | None | 19 | No | None | 18 | – | 0 |
| 29 | 40, F | Chondrosarcoma grade 1, distal femur, L | Curettage, plate | 60 | Latex | 25 | No | None | 18 | – | 0 |
| 30 | 15, M | Juvenile bone cyst, proximal humerus, R | Curettage, allograft | 45 | None | No | No | Soft tissue cyst | 9 | 55 | 1 |
| 31 | 14, M | Juvenile bone cyst, proximal humerus, R | Curettage, allograft | 40 | None | No | No | Aseptic inflammation | 12 | 41 | 2 |
L = left; R = right; NA = not available; *unclear whether the pain was associated with geneX®.